Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-0299-2022

Drug recall · January 5, 2022

Veklury recall

Why: Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Lots / codes

Lots: 2141001-1A, 2141002-1A, Exp. 01/2024

Quantity
53,473 vials
Company
Gilead Sciences, Inc., Foster City, CA
Distribution
Nationwide in the USA
Initiated
December 3, 2021 · Voluntary: Firm initiated
Classified
December 28, 2021
Reported
January 5, 2022
Ended
July 25, 2022
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.